ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,540Medicare Part D Prescriptions Filled, Including Refills

Rank: 481 out of 3734

$560K Total Retail Price of All Prescriptions

Rank: 567 out of 3734

350 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 350 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 350 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 7,254 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 463 362 1 1
LISINOPRIL 457 325 2 3
LEVOTHYROXINE SODIUM 323 258 3 2
METFORMIN HCL 296 202 4 8
WARFARIN SODIUM 277 252 5 10
AMLODIPINE BESYLATE 271 237 6 5
FUROSEMIDE 258 191 7 7
OMEPRAZOLE 204 133 8 4
METOPROLOL TARTRATE 191 168 9 6
ENDOCET 187 43 S2 10 89
ATORVASTATIN CALCIUM 184 130 11 11
ALLOPURINOL 174 113 12 33
HYDROCODONE-ACETAMINOPHEN 156 86 S3 13 12
METOPROLOL SUCCINATE 147 123 14 14
PRAVASTATIN SODIUM 139 95 15 15
ATENOLOL 134 94 16 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 130 101 17 27
HYDROCHLOROTHIAZIDE 125 85 18 9
PANTOPRAZOLE SODIUM 118 92 19 22
OXYCODONE-ACETAMINOPHEN 115 64 S2 20 51
SERTRALINE HCL 105 82 21 18
FAMOTIDINE 98 55 22 60
LOVASTATIN 95 54 23 41
CITALOPRAM HBR 93 56 24 16
FLUTICASONE PROPIONATE 93 37 24 46
DONEPEZIL HCL 92 92 26 25
LOSARTAN POTASSIUM 91 59 27 21
VENTOLIN HFA 91 64 27 70
CARVEDILOL 89 57 29 30
ZOLPIDEM TARTRATE 88 59 30 24
TAMSULOSIN HCL 88 69 30 29
ISOSORBIDE MONONITRATE ER 83 79 32 34
RANITIDINE HCL 82 35 33 32
GABAPENTIN 79 33 34 17
TRAZODONE HCL 78 35 35 49
ADVAIR DISKUS 78 50 35 35
TRAMADOL HCL 77 40 37 20
CRESTOR 76 52 38 28
JANUVIA 75 35 39 50
GLIPIZIDE 69 34 40 57
CLONIDINE HCL 66 43 41 79
CLOPIDOGREL 63 51 42 23
AMLODIPINE BESYLATE-BENAZEPRIL 57 44 43 56
AMOXICILLIN 56 33 44 108
ALENDRONATE SODIUM 56 44 44 26
IBUPROFEN 56 32 44 75
LANTUS SOLOSTAR 55 45 47 102
GEMFIBROZIL 55 33 47 114
PLAVIX 55 47 47 39
NEXIUM 54 38 50 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.